Antiulcer
Posaconazole 100 mg delayed‑release (gastro‑resistant) tablets are preferred over suspension for:Once‑daily dosing (convenient for long‑term prophylaxis and treatment) .Better bioavailability with more predictable blood levels, even in fasted state .Fewer GI side effects and easier administration compared to oral suspension .Common uses include:Prophylaxis in neutropenic patients (e.g., leukemia, transplant recipients) Treatment of invasive aspergillosis and other serious fungal infections Management of refractory candidiasis and mucormycosis in high‑risk patients